AGN.CN
Algernon Pharmaceuticals Inc
Price:  
0.07 
CAD
Volume:  
30,660.00
Canada | N/A
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

AGN.CN WACC - Weighted Average Cost of Capital

The WACC of Algernon Pharmaceuticals Inc (AGN.CN) is 4.5%.

The Cost of Equity of Algernon Pharmaceuticals Inc (AGN.CN) is 5.25%.
The Cost of Debt of Algernon Pharmaceuticals Inc (AGN.CN) is 5.00%.

Range Selected
Cost of equity 4.00% - 6.50% 5.25%
Tax rate 25.90% - 26.50% 26.20%
Cost of debt 5.00% - 5.00% 5.00%
WACC 3.8% - 5.1% 4.5%
WACC

AGN.CN WACC calculation

Category Low High
Long-term bond rate 3.2% 3.7%
Equity market risk premium 5.1% 6.1%
Adjusted beta 0.16 0.38
Additional risk adjustments 0.0% 0.5%
Cost of equity 4.00% 6.50%
Tax rate 25.90% 26.50%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 3.8% 5.1%
Selected WACC 4.5%